WFDC2 and neoplasm: Interestingly, WFDC2 levels after cycle 4 were not significantly different from baseline levels, which may indicate that, in some patients, WFDC2 levels stabilize or decline after initial elevation, possibly reflecting immune activation or reduced tumor burden in responders.